Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 22289023)

1.

Effects of methylnaltrexone in patients with narcotic bowel syndrome: a pilot observational study.

Gibson PR, Morrison G.

Intern Med J. 2012 Aug;42(8):907-12. doi: 10.1111/j.1445-5994.2012.02726.x.

PMID:
22289023
3.

Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.

Lipman AG, Karver S, Cooney GA, Stambler N, Israel RJ.

J Pain Palliat Care Pharmacother. 2011;25(2):136-45. doi: 10.3109/15360288.2011.573531.

PMID:
21657861
4.

Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome.

Drossman DA, Morris CB, Edwards H, Wrennall CE, Weinland SR, Aderoju AO, Kulkarni-Kelapure RR, Hu YJ, Dalton C, Bouma MH, Zimmerman J, Rooker C, Leserman J, Bangdiwala SI.

Am J Gastroenterol. 2012 Sep;107(9):1426-40. doi: 10.1038/ajg.2012.142. Epub 2012 Jun 19.

PMID:
22710577
5.

Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.

Michna E, Blonsky ER, Schulman S, Tzanis E, Manley A, Zhang H, Iyer S, Randazzo B.

J Pain. 2011 May;12(5):554-62. doi: 10.1016/j.jpain.2010.11.008. Epub 2011 Mar 22.

PMID:
21429809
6.

Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials.

Slatkin NE, Lynn R, Su C, Wang W, Israel RJ.

J Pain Symptom Manage. 2011 Nov;42(5):754-60. doi: 10.1016/j.jpainsymman.2011.02.015.

PMID:
22045373
7.

Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.

Iyer SS, Randazzo BP, Tzanis EL, Schulman SL, Zhang H, Wang W, Manley AL.

Value Health. 2011 Jan;14(1):177-83. doi: 10.1016/j.jval.2010.11.003.

PMID:
21211500
8.

Methylnaltrexone: MNTX.

[No authors listed]

Drugs R D. 2006;7(6):374-8. Review.

PMID:
17073520
9.

Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.

Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ.

J Pain Symptom Manage. 2008 May;35(5):458-68. doi: 10.1016/j.jpainsymman.2007.12.005.

PMID:
18440447
10.

Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.

Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ.

J Pain Symptom Manage. 2009 Nov;38(5):683-90. doi: 10.1016/j.jpainsymman.2009.02.234. Epub 2009 Aug 26.

PMID:
19713070
11.

Efficacy of subcutaneous methylnaltrexone in the treatment of opioid-induced constipation: a responder post hoc analysis.

Michna E, Weil AJ, Duerden M, Schulman S, Wang W, Tzanis E, Zhang H, Yu D, Manley A, Randazzo B.

Pain Med. 2011 Aug;12(8):1223-30. doi: 10.1111/j.1526-4637.2011.01189.x. Epub 2011 Aug 2.

PMID:
21810165
12.
13.

Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study.

Kariv R, Tiomny E, Grenshpon R, Dekel R, Waisman G, Ringel Y, Halpern Z.

Dig Dis Sci. 2006 Dec;51(12):2128-33. Epub 2006 Nov 1.

PMID:
17080248
14.

Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.

Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R.

J Support Oncol. 2009 Jan-Feb;7(1):39-46.

PMID:
19278178
15.

Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone.

Garten L, Degenhardt P, Bührer C.

J Pediatr Surg. 2011 Mar;46(3):e13-5. doi: 10.1016/j.jpedsurg.2010.10.015.

PMID:
21376180
16.

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.

Kurz A, Sessler DI.

Drugs. 2003;63(7):649-71. Review.

PMID:
12656645
17.

Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.

Lee JM, Mooney J.

Clin J Pain. 2012 May;28(4):338-41. doi: 10.1097/AJP.0b013e31822ad94c.

PMID:
21876436
18.
19.

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.

Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J; OBIS Study Investigators.

Aliment Pharmacol Ther. 2011 Aug;34(4):432-42. doi: 10.1111/j.1365-2036.2011.04730.x. Epub 2011 Jun 16.

PMID:
21679214
20.

A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.

Shaiova L, Rim F, Friedman D, Jahdi M.

Palliat Support Care. 2007 Jun;5(2):161-6. Review.

PMID:
17578067
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk